beta
Trial Radar AI

Showing clinical trials for Diabetes Mellitus, Type 2.

I can help you find nearby clinical trials and understand health conditions and treatments.
22 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Diabetes Mellitus, Type 2
×
 
Intervention
GLP-1, SGLT2 inhibitor
×
 
Study Title
Status
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination NCT03878706
Recruiting
Transformative Research in Diabetic Nephropathy 2.0 (TRIDENT 2) NCT07444203
Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM (STABLE-GLP1) NCT07314684
Recruiting
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh NCT06449235
Not yet recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Active, not recruiting
Surgical or Medical Treatment (ST2OMP) NCT04128995
Active, not recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (MESSAGE) NCT07244003
Recruiting
Rubix LS Diabetic Kidney Disease (DKD) Registry Study NCT07348718
Active, not recruiting
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (EPHIC-DIA2) NCT06851962
Active, not recruiting
CGM Use in Adults With Type 2 Diabetes on Basal Insulin NCT05944432
Active, not recruiting
Genetics of Response to Canagliflozin NCT02891954
Active, not recruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD (ADIPO-CKD) NCT07309094
Recruiting
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms NCT07073053
Not yet recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5) NCT06534411
Active, not recruiting
Effects of VLCKD in Metabolic Syndrome (KETO-MI) NCT05275608
Recruiting
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes NCT05313529
Active, not recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK) NCT05938712
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor NCT06221969
Active, not recruiting
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes NCT06593314
Recruiting
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) NCT05040087
Active, not recruiting